Sanfilippo syndrome
2023 - 12 - 7
Kyowa Kirin acquires rights to OTL-201 for Sanfilippo syndrome type A (Sanfilippo News)
The Japanese pharmaceutical Kyowa Kirin portfolio will soon include the OTL-201 gene therapy for Sanfilippo syndrome type A, after the company announce the ...
Explore the last week
- 2024 - 11 - 05, 33 topics across 262 articles.
- 2024 - 11 - 04, 59 topics across 742 articles.
- 2024 - 11 - 03, 42 topics across 588 articles.
- 2024 - 11 - 02, 57 topics across 723 articles.
- 2024 - 11 - 01, 39 topics across 458 articles.
- 2024 - 10 - 31, 53 topics across 580 articles.
- 2024 - 10 - 30, 46 topics across 668 articles.